Delivery Order SPE2DB20D1004-SPE2DB25FNFFB

Award Date 2/27/25
Potential Completion Date 2/28/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,255.27, is for the delivery of Telmisartan-HCTZ 80-25 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 29, 2024. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,760.39, is for the delivery of telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The contract has an ultimate completion date of January 8, 2024 and is a firm fixed-price delivery order. There is no set-aside designation for this award. Amerisourcebergen also holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,644.21 firm fixed-price delivery order is for the supply of Telmisartan-HCTZ 80-25 mg tablets. The contract has an ultimate completion date of February 6, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,649.30, is for the delivery of Telmisartan-HCTZ 40-12.5 mg Tablets in 30-count blister packs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 31, 2024. Amerisourcebergen also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,840.95, is for the delivery of Telmisartan-HCTZ 80-25 mg tablets in quantities of 30 per unit. This is a firm-fixed price delivery order contract with a completion date of January 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a large Indefinite Delivery...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $7,517.54, is a Delivery Order contract for the supply of Telmisartan-HCTZ 80-25 mg tablets. The contract has an ultimate completion date of April 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,390.87, is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in units of 30. It is a firm fixed-price delivery order contract with a completion date of February 27, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $4,412.35, is for the delivery of telmisartan-HCTZ 80-12.5 mg tablets. This is a firm fixed price delivery order contract with an ultimate completion date of January 29, 2025. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,546.03 firm fixed-price delivery order is for the supply of Telmisartan-HCTZ 80-25 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $24,816.32, is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in units of 30. The contract is a Firm Fixed Price Delivery Order with a completion date of February 21, 2024. The award was made on February 20, 2024 and there was no set-aside designation. AmerisourceBergen holds a...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNFFB
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,039.24, is for the delivery of Telmisartan-HCTZ 80-25 mg tablets in 30-count units. The contract is a Firm Fixed Price Delivery Order with a period of performance running through February 28, 2025. There is no set-aside designation associated with this award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 6/1/25, 3:21 AM